HSR21-051: Treatment Outcomes Among HR+/HER2- Advanced/Metastatic Breast Cancer Patients Receiving CDK 4 & 6 Inhibitors in a United States Clinical Practice Setting

Authors:
Yu-Jing Huang Eli Lilly and Company, Indianapolis, IN

Search for other papers by Yu-Jing Huang in
Current site
Google Scholar
PubMed Close
 PhD
,
Paula D. Ryan Texas Oncology - The Woodlands, The Woodlands, TX

Search for other papers by Paula D. Ryan in
Current site
Google Scholar
PubMed Close
 MD, PhD
,
Gregory L. Price Eli Lilly and Company, Indianapolis, IN

Search for other papers by Gregory L. Price in
Current site
Google Scholar
PubMed Close
 MPH
,
Gebra Cuyun Carter Eli Lilly and Company, Indianapolis, IN

Search for other papers by Gebra Cuyun Carter in
Current site
Google Scholar
PubMed Close
 PhD
,
Kristin M. Sheffield Eli Lilly and Company, Indianapolis, IN

Search for other papers by Kristin M. Sheffield in
Current site
Google Scholar
PubMed Close
 PhD
,
Emily Nash Smyth Eli Lilly and Company, Indianapolis, IN

Search for other papers by Emily Nash Smyth in
Current site
Google Scholar
PubMed Close
 PharmD
,
Claudia Morato Guimaraes Eli Lilly and Company, Indianapolis, IN

Search for other papers by Claudia Morato Guimaraes in
Current site
Google Scholar
PubMed Close
 MD
,
Sarah Rybowski Eli Lilly and Company, Indianapolis, IN

Search for other papers by Sarah Rybowski in
Current site
Google Scholar
PubMed Close
 MD
,
Jonathan Rajkumar McKesson Life Sciences, The Woodlands, TX

Search for other papers by Jonathan Rajkumar in
Current site
Google Scholar
PubMed Close
 MPH
, and
Lavanya Sudharshan McKesson Life Sciences, The Woodlands, TX

Search for other papers by Lavanya Sudharshan in
Current site
Google Scholar
PubMed Close
 MS
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7739
Restricted access

Corresponding Author: Yu-Jing Huang, PhD
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1800 1105 303
PDF Downloads 311 0 0
EPUB Downloads 0 0 0